Last updated: May 9, 2026
Who Supplies Heparin Sodium 5,000 Units With 0.9% Sodium Chloride in Plastic Containers?
What are the supply-chain targets for this drug product?
A commercial supply strategy for “Heparin Sodium 5,000 Units” administered with “Sodium Chloride 0.9%” in a plastic container typically resolves into two procurement lanes:
-
Heparin sodium injection (5,000 Units dose and/or vial strength)
- Supplier(s): the marketing authorization holder (brand owner) and/or contract manufacturers (CMOs) producing finished heparin drug product under approved packaging and labeling.
-
0.9% sodium chloride injection in a plastic container (common as IV flush/infusion solution)
- Supplier(s): the finished drug product vendor producing the sodium chloride solution in a plastic container (commonly via PE or PVC-free plastic systems used for IV solutions).
Because the request names only the active ingredients and container format (plastic) but not the finished product configuration (single-agent versus premixed combination), the procurement approach depends on whether the clinician receives:
- Separate injections (heparin + saline sourced independently), or
- A fixed combination (heparin co-packaged or compounded into the saline solution in a regulated manner).
Under either pathway, “suppliers” in a patent-and-regulatory context map to the approved manufacturers of the finished drug products (not raw material heparin API alone).
What suppliers make heparin sodium injection (typical market participants)?
For heparin sodium injection products globally (including the US/EU supply chains), named manufacturers that repeatedly appear across tendering, product listings, and regulatory submissions include:
- Baxter Healthcare
- Hospira (Pfizer)
- Sandoz
- Mylan/Viatris
- B. Braun
- Hikma Pharmaceuticals
- Biosense or local-market regional entrants (varies by jurisdiction)
These entities typically supply heparin sodium as:
- vials or multi-dose containers, with labeled unit strengths (often including 1 mL or 5 mL presentations), depending on national packaging conventions.
What suppliers make 0.9% sodium chloride injection in plastic containers (typical market participants)?
For 0.9% sodium chloride injection in plastic containers, major global suppliers include:
- B. Braun
- Fresenius Kabi
- Baxter Healthcare
- Hospira (Pfizer)
- McGuff Pharmaceuticals and other regional distributors (jurisdiction-dependent)
This lane is often dominated by large-scale IV solution manufacturers because sodium chloride is a high-volume commodity product with strict container and leak testing requirements.
How do suppliers differ if the product is separate dosing versus a premixed combination?
Procurement and supplier identification changes based on the clinical packaging model:
What evidence-based supplier lists can be produced from patent-grade sources?
A patent-grade “supplier” list requires the following to be provable from public regulatory artifacts:
- the exact finished dosage form of heparin sodium (vial size, unit concentration, packaging),
- the exact saline container format (bag type, volume, material, free-radical scavenger?),
- the country-specific approved products (since supplier rosters differ sharply by market),
- the regulatory listing (FDA NDC in US; EMA national listings in EU; MHRA listings in UK; etc.).
With only the phrase “HEPARIN SODIUM 5,000 UNITS AND SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER,” any supplier list would require guessing the finished presentation and jurisdiction, which does not meet a hard-data standard for an analyst deliverable.
Key Takeaways
- The supply chain decomposes into heparin drug product suppliers and 0.9% sodium chloride IV solution suppliers; the supplier roster depends on whether the user wants separate dosing or a regulatory premix/co-packaged product.
- Large global participants repeatedly present in heparin and IV saline manufacturing include Baxter, B. Braun, Fresenius Kabi, Hospira (Pfizer), Sandoz, Mylan/Viatris, and Hikma for these respective categories, but a provable, jurisdiction-accurate supplier list for the exact “5,000 units” presentation and plastic container format cannot be produced from the provided input alone.
FAQs
-
Are heparin sodium 5,000 units and 0.9% sodium chloride usually supplied as a single premixed product?
In many markets they are sourced as separate products unless a specific authorized combination configuration exists.
-
Do container materials affect supplier selection for 0.9% sodium chloride?
Yes. Plastic IV solution container systems are material-specific and tied to validated manufacturing, closure systems, and regulatory submissions.
-
Do raw material API suppliers count as “drug suppliers” for tenders?
Typically not. Hospitals and procurement contracts usually target the finished drug product manufacturers.
-
Does the supplier list change by country?
Yes. Approved product lineups and manufacturing networks differ across FDA, EMA, MHRA, and national regulators.
-
Is the “5,000 units” specification enough to identify the correct heparin product?
No. Finished packaging (vial volume, unit concentration, and container presentation) must match the regulated product label.
References
[1] FDA. “Drug Products: Current and Historical Product Information.” U.S. Food and Drug Administration. https://www.accessdata.fda.gov/scripts/cder/daf/
[2] EMA. “European Medicines Agency: Medicines (human).” European Medicines Agency. https://www.ema.europa.eu/en/medicines
[3] MHRA. “Medicines: Finding medicines.” Medicines and Healthcare products Regulatory Agency (UK). https://www.gov.uk/government/organisations/medicines-and-healthcare-products-regulatory-agency
